Mutants of Francisella tularensis and uses thereof

US8993302B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8993302-B2
Application numberUS-201013266466-A
CountryUS
Kind codeB2
Filing dateApr 23, 2010
Priority dateApr 29, 2009
Publication dateMar 31, 2015
Grant dateMar 31, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a mutant Francisella tularensis strain comprising an inactivated clpB gene and compositions comprising such mutant. Methods of producing the mutant are also described. The present invention also encompasses a method of conferring immunity against F. tularensis in a host, comprising administering the described mutant F. tularensis strain.

First claim

Opening claim text (preview).

The invention claimed is: 1. An attenuated Francisella tularensis mutant strain wherein the caseinolytic peptidase B (c/pB) gene is deleted, wherein the mutant is a variant of the wild-type clinical strain of F. tularensis selected from the group consisting of SCHU S4, FS033, FSC 108 and FSC 200. 2. The mutant F. tularensis strain of claim 1 , wherein the mutant is more attenuated than F. tularensis LVS. 3. The mutant F. tularensis…

Assignees

Inventors

Classifications

  • Chemistry & Metallurgy · mapped topic

  • Human Necessities · mapped topic

  • C12N9/90Primary

    Chemistry & Metallurgy · mapped topic

  • Human Necessities · mapped topic

  • Cross-Sectional Technologies · mapped topic

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8993302B2 cover?
The present invention relates to a mutant Francisella tularensis strain comprising an inactivated clpB gene and compositions comprising such mutant. Methods of producing the mutant are also described. The present invention also encompasses a method of conferring immunity against F. tularensis in a host, comprising administering the described mutant F. tularensis strain.
Who is the assignee on this patent?
Conlan Joseph Wayne, Sjostedt Anders, Nat Res Council Canada
What technology area does this patent fall under?
Primary CPC classification C12N9/90. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).